Latest News: 10 July 2011
Mr Stephen Pearce, Chief Financial Officer of Fortescue Metals Group Ltd, has been appointed as an Advisor to the Board of BioProspect Limited (BPO)
- BPO is to undertake a simplification of its corporate structure and at the same time raise $2,000,000 by the issue of fully paid ordinary shares at a price of $0.003 each to accelerate validation trials and commercialisation of the Smart Phone App.
Currently independent validation trials are being conducted in the USA and Australia
ASX
Market Update:
The Board welcomes Mr Stephen Pearce as an
adviser to assist in its next important phase of development. Mr Pearce is the
Chief Financial Officer of Fortescue Metals Group Ltd having joined Fortescue
in March 2010. In that time he has raised approximately US$12 billion to
support the growth of Fortescue’s iron ore operations.
Mr Pearce will provide strategic,
commercial and corporate guidance to the Board of BPO. Mr Pearce has extensive
experience in debt and equity markets in Australia, Asia and the United States.
Mr Pearce will advise the Board through this important phase of development
funding and commercialisation in addition to the establishment of a Medical
Advisory Board and assistance in the appointment of new Board members as the
Company enters into the next phase of growth.
Stay Tuned!!
